COVID-19 and HIV: Clinical Outcomes and Inflammatory Markers in a Cohort from a Reference Hospital in Rio de Janeiro, Brazil
Authors:
- Nathalia Beatriz Ramos de SáNSNathalia Beatriz Ramos de Sá
- Karine Venegas MacieiraKMKarine Venegas Macieira
- Mariana Rosa Inacio CoelhoMariana Rosa Inacio Coelho
- Milena Neira GoulartMGMilena Neira Goulart
- Marcelo Ribeiro-AlvesMRMarcelo Ribeiro-Alves
- Leonardo Azevedo da Silva RosadasLRLeonardo Azevedo da Silva Rosadas
- Kim Mattos GeraldoKGKim Mattos Geraldo
- Maria Pia Diniz RibeiroMRMaria Pia Diniz Ribeiro
- Sandra Wagner CardosoSCSandra Wagner Cardoso
- Beatriz GrinsztejnBGBeatriz Grinsztejn
- Valdiléa G. VelosoVVValdiléa G. Veloso
- Andressa da Silva CazoteACAndressa da Silva Cazote
Open Access
Abstract
Background: Severe COVID-19 presents a variety of clinical manifestations associated with inflammatory profiles. People living with HIV (PLWH) could face a higher risk of hospitalization and mortality from COVID-19, depending on their immunosuppression levels. This study describes inflammatory markers in COVID-19 clinical outcomes with and without HIV infection. Methods: We analyzed 112 inpatients of the Hospital Center for COVID-19 (INI/FIOCRUZ), including 22 cases of COVID-19 in PLWH (COVID/PLWH group). Plasma samples were tested for a panel of 15 cytokines by Luminex. Sociodemographic, clinical, and laboratory data were collected from patients’ clinical records. Results: COVID-19 individuals were stratified according to the WHO clinical severity profiles at hospitalization. Significant differences in clinical scores, symptoms (coughs), and the occurrence of HIV infection were found among the groups. Clinical blood parameters and plasma cytokines were analyzed among COVID-19 groups with distinct severity profiles. Critical COVID-19 cases showed higher levels of inflammatory markers (Bilirubin, D-dimer, PCR, and urea, as well as IL-8, IL-10, TNF-α, INF-α, IL-1β, IL-17A, IL-23, IL-6) than moderate and severe groups. The COVID/PLWH group had lower CD4 counts (64 cells/mm3) and cytokine levels than other COVID-19 patients. Conclusions: Overall, critically ill COVID-19 patients exhibited heightened inflammatory responses, while COVID/PLWH demonstrated unique immunological characteristics without increased mortality risk.Keywords
All Related Versions
Funding Information
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (SEI-260003/002689/2020, SEI-260003/013002/2021, 48401996705881, E-26/205.940/2022, 312574/2022-3, E-26/201.177/2021)
- Inova Fiocruz/Fundação Oswaldo Cruz (SEI-260003/002689/2020, SEI-260003/013002/2021, 48401996705881, E-26/205.940/2022, 312574/2022-3, E-26/201.177/2021)
- Nathalia Beatriz Ramos de Sá is the recipient of FAPERJ (SEI-260003/002689/2020, SEI-260003/013002/2021, 48401996705881, E-26/205.940/2022, 312574/2022-3, E-26/201.177/2021)
- Mariza Gonçalves Morgado is recipient of CNPQ (SEI-260003/002689/2020, SEI-260003/013002/2021, 48401996705881, E-26/205.940/2022, 312574/2022-3, E-26/201.177/2021)
- FAPERJ (SEI-260003/002689/2020, SEI-260003/013002/2021, 48401996705881, E-26/205.940/2022, 312574/2022-3, E-26/201.177/2021)
This publication has 30 references indexed in Scilit:
- Inflammasome genes polymorphisms are associated with progression to mechanical ventilation and death in a cohort of hospitalized COVID-19 patients in a reference hospital in Rio de Janeiro, BrazilGene, 2023
- In-hospital mortality and severe outcomes after hospital discharge due to COVID-19: A prospective multicenter study from BrazilThe Lancet Regional Health - Americas, 2022
- Risk and Protective Factors for COVID-19 Morbidity, Severity, and MortalityClinical Reviews in Allergy & Immunology, 2022
- Impact of COVID-19 on people living with HIV: A reviewJournal of Virus Eradication, 2020
- Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 (Covid‐19)Diabetes/Metabolism Research and Reviews, 2020
- The Burden of COVID-19 in People Living with HIV: A Syndemic PerspectiveAIDS and Behavior, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive studyThe Lancet, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- From “A”IV to “Z”IKV: Attacks from Emerging and Re-emerging PathogensCell, 2018